1. Home
  2. GAUZ vs ENVB Comparison

GAUZ vs ENVB Comparison

Compare GAUZ & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gauzy Ltd. Ordinary Shares

GAUZ

Gauzy Ltd. Ordinary Shares

HOLD

Current Price

$0.50

Market Cap

8.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.41

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAUZ
ENVB
Founded
2009
1994
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
8.1M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
GAUZ
ENVB
Price
$0.50
$1.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
64.2K
142.9K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,914,675.00
Revenue This Year
$22.59
N/A
Revenue Next Year
$59.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.56
52 Week High
$7.50
$13.25

Technical Indicators

Market Signals
Indicator
GAUZ
ENVB
Relative Strength Index (RSI) 41.63 38.81
Support Level $0.48 $0.58
Resistance Level $0.72 $2.13
Average True Range (ATR) 0.07 0.15
MACD -0.01 0.05
Stochastic Oscillator 24.49 40.43

Price Performance

Historical Comparison
GAUZ
ENVB

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: